Literature DB >> 3285344

Saturation mutagenesis of a major histocompatibility complex protein domain: identification of a single conserved amino acid important for allorecognition.

R Murray1, C A Hutchison, J A Frelinger.   

Abstract

The interactive association between T lymphocytes and their target cells is an important system of cell-cell interactions. Major histocompatibility complex class I molecules are the cell surface structures recognized by cytolytic T lymphocytes. To define the molecular structures recognized by cytotoxic T lymphocytes, we have saturated the 270-base-pair alpha 1 exon of the H-2Dp gene with point mutations, rapidly producing a "library" of 2.5 x 10(3) independent mutants. The library contains enough recombinant clones (each clone encoding approximately one amino acid replacement mutation) to predict a mutation at each nucleotide position of the alpha 1 exon. The functional analysis of the first five transfected gene products tested has shown that mutation of a conserved tyrosine at position 27 to asparagine destroys recognition of the H-2Dp gene product by polyclonal alloreactive cytotoxic T lymphocytes. Recognition of the same mutant molecule by three monoclonal antibodies and H-2-restricted lymphocytic choriomenengitis virus-specific cytotoxic T lymphocytes is unaffected.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3285344      PMCID: PMC280247          DOI: 10.1073/pnas.85.10.3535

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  The alpha 1 and alpha 2 domains of H-2 class I molecules interact to form unique epitopes.

Authors:  T Kanda; K LaPan; H Takahashi; E Appella; J A Frelinger
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

2.  The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides.

Authors:  A R Townsend; J Rothbard; F M Gotch; G Bahadur; D Wraith; A J McMichael
Journal:  Cell       Date:  1986-03-28       Impact factor: 41.582

3.  An approach to the study of structure-function relationships of MHC class I molecules: isolation and serologic characterization of H-2Kb somatic cell variants.

Authors:  S S Geier; R A Zeff; D M McGovern; T V Rajan; S G Nathenson
Journal:  J Immunol       Date:  1986-08-15       Impact factor: 5.422

4.  The nucleotide sequence and comparative analysis of the H-2Dp class I H-2 gene.

Authors:  B S Schepart; H Takahashi; K M Cozad; R Murray; K Ozato; E Appella; J A Frelinger
Journal:  J Immunol       Date:  1986-05-01       Impact factor: 5.422

5.  Monoclonal antibodies defining mouse tissue antigens encoded by the H-2 region.

Authors:  K J Hasenkrug; J M Cory; J H Stimpfling
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

6.  Three closely linked genetic systems relevant to transplantation.

Authors:  E J Yunis; D B Amos
Journal:  Proc Natl Acad Sci U S A       Date:  1971-12       Impact factor: 11.205

7.  Isolation and characterization of antigen-Ia complexes involved in T cell recognition.

Authors:  S Buus; A Sette; S M Colon; D M Jenis; H M Grey
Journal:  Cell       Date:  1986-12-26       Impact factor: 41.582

8.  Cloning and identification of the H-2Dp gene.

Authors:  M J Macchi; J G Woodward; E McLaughlin-Taylor; J Griffin; L Hood; J A Frelinger
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

9.  Specific recognition of the product of a transferred major histocompatibility complex gene by cytotoxic T lymphocytes.

Authors:  J G Woodward; A Orn; R C Harmon; R S Goodenow; L Hood; J A Frelinger
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

10.  A single amino acid substitution in the alpha 3 domain of an H-2 class I molecule abrogates reactivity with CTL.

Authors:  T A Potter; J A Bluestone; T V Rajan
Journal:  J Exp Med       Date:  1987-10-01       Impact factor: 14.307

View more
  8 in total

1.  A cluster of mutations in HLA-A2 alpha 2 helix abolishes peptide recognition by T cells.

Authors:  R J Moots; M Matsui; L Pazmany; A J McMichael; J A Frelinger
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

2.  Analysis of novel residues of class I involved in recognition by alloreactive T cells.

Authors:  W R Heath; M E Hurd; R Murray; J Frelinger; L A Sherman
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

3.  Random oligonucleotide mutagenesis: application to a large protein coding sequence of a major histocompatibility complex class I gene, H-2DP.

Authors:  R Murray; K Pederson; H Prosser; D Muller; C A Hutchison; J A Frelinger
Journal:  Nucleic Acids Res       Date:  1988-10-25       Impact factor: 16.971

4.  Reversal of natural killing susceptibility in target cells expressing transfected class I HLA genes.

Authors:  W J Storkus; J Alexander; J A Payne; J R Dawson; P Cresswell
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

5.  The transport of class I major histocompatibility complex antigens is determined by sequences in the alpha 1 and alpha 2 protein domains.

Authors:  J Alexander; J A Payne; B Shigekawa; J A Frelinger; P Cresswell
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

6.  Differential transport requirements of HLA and H-2 class I glycoproteins.

Authors:  J Alexander; J A Payne; R Murray; J A Frelinger; P Cresswell
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

7.  Generation and analysis of random point mutations in an antibody CDR2 sequence: many mutated antibodies lose their ability to bind antigen.

Authors:  C Chen; V A Roberts; M B Rittenberg
Journal:  J Exp Med       Date:  1992-09-01       Impact factor: 14.307

8.  A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognition.

Authors:  Whitney A Macdonald; Anthony W Purcell; Nicole A Mifsud; Lauren K Ely; David S Williams; Linus Chang; Jeffrey J Gorman; Craig S Clements; Lars Kjer-Nielsen; David M Koelle; Scott R Burrows; Brian D Tait; Rhonda Holdsworth; Andrew G Brooks; George O Lovrecz; Louis Lu; Jamie Rossjohn; James McCluskey
Journal:  J Exp Med       Date:  2003-08-25       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.